Rédaction Africa Links 24 with CORRESPONDENT
Published on 2024-03-06 12:35:29
Kenya recently received a significant boost in its fight against cancer with the acquisition of a state-of-the-art cancer treatment calibration system. The Cobalt 60 radiotherapy calibration system, known for its precise calibration in delivering cancer treatments, was unveiled by Trade Cabinet Secretary Rebecca Miano at the Kenya Bureau of Standards (KEBS) headquarters.
The introduction of this cutting-edge system is expected to revolutionize cancer treatment procedures across the country. Trade Cabinet Secretary Miano highlighted that the precise radiation doses delivered by the system will enhance treatment effectiveness while minimizing associated side effects, ultimately improving patient safety and therapeutic outcomes.
The Managing Director of KEBS, Esther Ngari, emphasized the collaborative efforts with the International Atomic Energy Agency (IAEA) that have led to the acquisition of the Cobalt 60 system. This collaboration has been instrumental in promoting innovation and enhancing capacity building in cancer treatment over the years.
According to the World Health Organization (WHO), cancer is the second leading cause of death globally, surpassing cardiovascular diseases. In Kenya, the Ministry of Health ranks cancer as the third leading cause of death after infectious and cardiovascular diseases.
The acquisition of the Cobalt 60 radiotherapy calibration system marks a significant milestone in Kenya’s efforts to improve cancer care and treatment outcomes. The system’s advanced technology and precise calibration capabilities will enable healthcare providers to deliver more effective and targeted cancer treatments, leading to better outcomes for patients.
In addition to enhancing treatment effectiveness, the new system is expected to minimize the side effects associated with cancer treatment, ultimately improving the quality of life for cancer patients in Kenya. By ensuring precise radiation doses, the Cobalt 60 system will optimize the therapeutic impact of treatments while reducing the risks of unnecessary side effects.
The introduction of this state-of-the-art cancer treatment calibration system demonstrates Kenya’s commitment to advancing cancer care and treatment standards in the country. Through strategic collaborations with organizations like the IAEA, Kenya is harnessing innovative technologies to enhance its capacity in cancer treatment and care, ultimately improving the health outcomes of its population.
Overall, the acquisition of the Cobalt 60 radiotherapy calibration system represents a significant step forward in Kenya’s fight against cancer. By investing in cutting-edge technology and fostering international partnerships, Kenya is positioning itself as a leader in cancer care and treatment in the region. This milestone serves as a testament to the country’s dedication to improving healthcare services and outcomes for cancer patients nationwide.
Read the original article on Africa News 24
